pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
EBC-129
Pancreatic Ductal Adenocarcinoma
Agency for Science, Technology and Research
0
catalysts
Phase 2
EEDVD-682
Pancreatic Ductal Adenocarcinoma
EnGeneIC Ltd
0
catalysts
Phase 2
EF-001
Anaplastic Astrocytoma
Everfront Biotech Inc
0
catalysts
Phase 2
EG-007
Endometrial Cancer
← prev
page 18 of 62
next →
131
Pain
89
Neurology
1
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
0
catalysts
Phase 2
EIS-12656
Breast Cancer
Eisbach Bio GmbH
0
catalysts
Phase 2
ELI-002 2P
Colorectal Cancer
$ELTX
Elicio Therapeutics, Inc.
0
catalysts
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVN
Enliven Therapeutics, Inc.
0
catalysts
Phase 2
ELVN-002
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
$ELVN
Enliven Therapeutics, Inc.
0
catalysts
Phase 2
ENB-003
Pancreatic Cancer
ENB Therapeutics LLC
0
catalysts
Phase 2
EO-2463
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
Enterome Bioscience SA
0
catalysts
Preclinical
EPS-401
Non-Small Cell Lung Cancer
Epsilogen Ltd
0
catalysts
Phase 1
ERAS-4001
Solid Tumor
$ERAS
Erasca, Inc.
0
catalysts
Phase 2
ERC-1671
Gliovac
Gliosarcoma
ERC Belgium SA
0
catalysts
Preclinical
ERNA-101
Ovarian Cancer
$ERNA
Ernexa Therapeutics Inc.
0
catalysts
Phase 1
ERSM-5404
Colorectal Cancer
Hibercell Inc
0
catalysts
Phase 2
ET-1402
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0
catalysts
Phase 2
ETX-19477
Ovarian Cancer
858 Therapeutics Inc
0
catalysts
Phase 2
ETX-636
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
ENSEM Therapeutics Inc
0
catalysts
Phase 2
EU-101
Colorectal Cancer
Eutilex Co Ltd
0
catalysts
Phase 2
EVM-14
Esophageal Squamous Cell Carcinoma (ESCC)
Everest Medicines Ltd
0
catalysts
Phase 1
EVOLVE-104
Anal Cancer
EvolveImmune Therapeutics Inc
0
catalysts
Phase 2
EVX-01
Metastatic Melanoma
$EVAX
Evaxion A/S
0
catalysts
Preclinical
EX-501
Unspecified Cancer
Exinda Therapeutics LLC
0
catalysts
Preclinical
Engineered Virus
Glioblastoma Multiforme (GBM)
Kopra Bio Inc
0
catalysts
Phase 2
FB-849
Solid Tumor
1st Bio Therapeutics Inc
0
catalysts
Phase 2
FF-10502-01
Solid Tumor
Fujifilm Holdings Corp
0
catalysts
Phase 3
FG-3246
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$KYNB
KYNTRA BIO, INC.
0
catalysts
Preclinical
FID-021
Unspecified Cancer
Fulgent Pharma LLC
0
catalysts
Phase 1
FID-022
Solid Tumor
Fulgent Pharma LLC
0
catalysts
